Search research articles
Contact Us
Filters
Showing results (291-300 of 583) with videos related to
Page
of 59
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 18, 2026
Response to Ma et al
Adam F Kemp, Simon Anhøj, Anna Mejldal, et al.
Psychiatry and Clinical Neurosciences
|
November 13, 2025
Catatonia and elevated mortality: A population-wide cohort study with healthy, sibling, and schizophrenia spectrum controls
Chih-Wei Hsu, Yang-Chieh Brian Chen, Marco Solmi, et al.
Schizophrenia Bulletin
|
November 16, 2017
Prevalence of Catatonia and Its Moderators in Clinical Samples: Results from a Meta-analysis and Meta-regression Analysis
Marco Solmi, G Giorgio Pigato, Beatrice Roiter, et al.
International Journal of Environmental Research and Public Health
|
August 28, 2025
Health, Psychological Distress, and Functioning During the COVID-19 Pandemic Among Danish Adults with and Without a Preexisting Mental Illness
Per Vendsborg, Nanna Schneekloth Jarlstrup, Sofie H Hoffmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 5, 2016
Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: a systematic review and meta-analysis
Pinar Soysal, Ahmet Turan Isik, Brendon Stubbs, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 9, 2023
Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies
Natacha Perez, Florent Langlest, Luc Mallet, et al.
JAMA Psychiatry
|
September 27, 2023
Transition to Schizophrenia Spectrum Disorder Following Emergency Department Visits Due to Substance Use With and Without Psychosis
Daniel T Myran, Lyndsay D Harrison, Michael Pugliese, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
January 14, 2023
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de-risk trial programmes of novel agents
Christoph U Correll, Marco Solmi, Samuele Cortese, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
June 4, 2020
How can we improve antidepressant adherence in the management of depression? A targeted review and 10 clinical recommendations
Marco Solmi, Alessandro Miola, Giovanni Croatto, et al.
JAMA Network Open
|
February 4, 2025
Changes in Incident Schizophrenia Diagnoses Associated With Cannabis Use Disorder After Cannabis Legalization
Daniel T Myran, Michael Pugliese, Lyndsay D Harrison, et al.
Page
of 59
Search research articles
Search
Showing results (291-300 of 583) with videos related to
Sort By:
Page
of 59
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 18, 2026
Response to Ma et al
Adam F Kemp, Simon Anhøj, Anna Mejldal, et al.
Psychiatry and Clinical Neurosciences
|
November 13, 2025
Catatonia and elevated mortality: A population-wide cohort study with healthy, sibling, and schizophrenia spectrum controls
Chih-Wei Hsu, Yang-Chieh Brian Chen, Marco Solmi, et al.
Schizophrenia Bulletin
|
November 16, 2017
Prevalence of Catatonia and Its Moderators in Clinical Samples: Results from a Meta-analysis and Meta-regression Analysis
Marco Solmi, G Giorgio Pigato, Beatrice Roiter, et al.
International Journal of Environmental Research and Public Health
|
August 28, 2025
Health, Psychological Distress, and Functioning During the COVID-19 Pandemic Among Danish Adults with and Without a Preexisting Mental Illness
Per Vendsborg, Nanna Schneekloth Jarlstrup, Sofie H Hoffmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 5, 2016
Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: a systematic review and meta-analysis
Pinar Soysal, Ahmet Turan Isik, Brendon Stubbs, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
August 9, 2023
Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies
Natacha Perez, Florent Langlest, Luc Mallet, et al.
JAMA Psychiatry
|
September 27, 2023
Transition to Schizophrenia Spectrum Disorder Following Emergency Department Visits Due to Substance Use With and Without Psychosis
Daniel T Myran, Lyndsay D Harrison, Michael Pugliese, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
January 14, 2023
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de-risk trial programmes of novel agents
Christoph U Correll, Marco Solmi, Samuele Cortese, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
June 4, 2020
How can we improve antidepressant adherence in the management of depression? A targeted review and 10 clinical recommendations
Marco Solmi, Alessandro Miola, Giovanni Croatto, et al.
JAMA Network Open
|
February 4, 2025
Changes in Incident Schizophrenia Diagnoses Associated With Cannabis Use Disorder After Cannabis Legalization
Daniel T Myran, Michael Pugliese, Lyndsay D Harrison, et al.
Page
of 59